TQQQ:NSD-ProShares UltraPro QQQ

ETF | Drug Manufacturers | NASDAQ Global Market

Last Closing

USD 65.43

Change

-0.49 (-0.74)%

Market Cap

USD 1.13B

Volume

0.01B

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ-100 Index?. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as three times (3x) the daily return of the index. The index, a modified market capitalization-weighted index, includes 100 of the largest non-financial domestic and international issues listed on the NASDAQ Stock Market. The fund is non-diversified.

Inception Date: 09/02/2010

Primary Benchmark: NASDAQ 100 TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.01%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Drug Manufacturers

ETFs Containing TQQQ

GTAA 0.00 % 1.25 %

N/A

N/A
HUSE 0.00 % 0.91 %

N/A

N/A
QQH HCM Defender 100 Index ET.. 0.00 % 0.00 %

+0.26 (+0.47%)

USD 0.41B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 76.65% 100% F 93% A
Dividend Return 0.05% 20% F 1% F
Total Return 76.70% 100% F 93% A
Trailing 12 Months  
Capital Gain 7.88% 86% B+ 75% C
Dividend Return 0.10% 20% F 1% F
Total Return 7.98% 86% B+ 71% C-
Trailing 5 Years  
Capital Gain 468.87% 100% F 97% N/A
Dividend Return 0.57% 100% F 1% F
Total Return 469.45% 100% F 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 41.57% 100% F 92% A
Dividend Return 41.59% 100% F 92% A
Total Return 0.02% 20% F N/A F
Risk Return Profile  
Volatility (Standard Deviation) 47.51% 14% F 21% F
Risk Adjusted Return 87.55% 100% F 88% B+
Market Capitalization 1.13B 100% F 88% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.